✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Despite its poor effcacy, theophylline, which is a methylxanthine derivative, is being commonly used for the treatment of chronic obstructive pulmonary disease (COPD) worldwide for many years due to its low cost.
📊
Key Findings & Data:This drug with bronchodilator activity must be carefully used in the elderly.
💡
Conclusion & Impact:In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Despite its poor effcacy, theophylline, which is a methylxanthine derivative, is being commonly used for the treatment of chronic obstructive pulmonary disease (COPD) worldwide for many years due to its low cost. This drug with bronchodilator activity must be carefully used in the elderly. In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.
🔖
Cite This Article
BATUM, Ö., BATUM, M. (2014). A Rare adverse event induced by theophylline: Epilepsy. Türk Toraks Dergisi, Cilt: 15 - Sayı: 4, 172–174. https://ajindex.com/articles/329479